Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma. [electronic resource]
Producer: 20010607Description: 319-24 p. digitalISSN:- 0171-5216
- Adult
- Aged
- Anorexia -- chemically induced
- Antimetabolites, Antineoplastic -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Chills -- chemically induced
- Combined Modality Therapy
- Death, Sudden, Cardiac -- etiology
- Dose-Response Relationship, Drug
- Fatigue -- chemically induced
- Female
- Fever -- chemically induced
- Fluorouracil -- administration & dosage
- Humans
- Immunologic Factors -- administration & dosage
- Immunotherapy
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Life Tables
- Male
- Maximum Tolerated Dose
- Middle Aged
- Nausea -- chemically induced
- Recombinant Proteins -- administration & dosage
- Survival Analysis
- Thrombocytopenia -- chemically induced
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.